Literature DB >> 3877243

Plakalbumin, alpha 1-antitrypsin, antithrombin and the mechanism of inflammatory thrombosis.

R W Carrell, M C Owen.   

Abstract

An old puzzle in protein biochemistry concerns the ready conversion of ovalbumin, by proteolysis, to the much more stable derivative, plakalbumin. Ovalbumin is now known to belong to the serpin superfamily, most of which are serine proteinase inhibitors. We report here studies of two such members of the family, the human plasma proteins alpha 1-antitrypsin and antithrombin, and show that they undergo a similar change in stability on selective proteolysis. This change, which is accompanied by a loss of inhibitory activity, can best be considered as an irreversible molecular transition from a native stressed (S) conformation, to a more ordered relaxed (R) form. The maintenance of the native S conformation, and hence the maintenance of inhibitory activity, is critically dependent on the integrity of an exposed loop of polypeptide. We propose that the susceptibility of this peptide loop to proteolytic cleavage gives it an incidental role as a physiological switch which allows the inactivation of individual inhibitors by specific proteolysis. The vulnerability of this exposed loop in each inhibitor also explains the pathological action of a number of venoms and toxins. In particular, the demonstration here of the cleavage of antithrombin, by leukocyte elastase, explains an observed change in blood coagulation that accompanies severe inflammation and which can result in fatal thrombosis.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3877243     DOI: 10.1038/317730a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  40 in total

Review 1.  Protein misfolding and the serpinopathies.

Authors:  Didier Belorgey; Peter Hägglöf; Susanna Karlsson-Li; David A Lomas
Journal:  Prion       Date:  2007-01-06       Impact factor: 3.931

2.  Structural and functional characterization of a highly specific serpin in the insect innate immunity.

Authors:  Sun Hee Park; Rui Jiang; Shunfu Piao; Bing Zhang; Eun-Hye Kim; Hyun-Mi Kwon; Xiao Ling Jin; Bok Luel Lee; Nam-Chul Ha
Journal:  J Biol Chem       Date:  2010-11-03       Impact factor: 5.157

3.  Fluorescence-detected polymerization kinetics of human alpha 1-antitrypsin.

Authors:  H Koloczek; A Guz; P Kaszycki
Journal:  J Protein Chem       Date:  1996-07

4.  Interaction of murine intestinal mast cell proteinase with inhibitors (serpins) in blood; analysis by SDS-PAGE and western blotting.

Authors:  J Irvine; G F Newlands; J F Huntley; H R Miller
Journal:  Immunology       Date:  1990-01       Impact factor: 7.397

Review 5.  alpha 1-Antitrypsin: molecular pathology, leukocytes, and tissue damage.

Authors:  R W Carrell
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

6.  The N-terminal domain of antithrombin-III is essential for heparin binding and complex-formation with, but not cleavage by, alpha-thrombin.

Authors:  R C Austin; W P Sheffield; R A Rachubinski; M A Blajchman
Journal:  Biochem J       Date:  1992-03-01       Impact factor: 3.857

7.  Mechanistic characterization and crystal structure of a small molecule inactivator bound to plasminogen activator inhibitor-1.

Authors:  Shih-Hon Li; Ashley A Reinke; Karen L Sanders; Cory D Emal; James C Whisstock; Jeanne A Stuckey; Daniel A Lawrence
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  Type II hereditary angioneurotic edema that may result from a single nucleotide change in the codon for alanine-436 in the C1 inhibitor gene.

Authors:  N J Levy; N Ramesh; M Cicardi; R A Harrison; A E Davis
Journal:  Proc Natl Acad Sci U S A       Date:  1990-01       Impact factor: 11.205

9.  Administration of C1 inhibitor reduces neutrophil activation in patients with sepsis.

Authors:  Sacha Zeerleder; Christoph Caliezi; Gerard van Mierlo; Anke Eerenberg-Belmer; Irmela Sulzer; C Erik Hack; Walter A Wuillemin
Journal:  Clin Diagn Lab Immunol       Date:  2003-07

10.  Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation.

Authors:  K S Aulak; P A Pemberton; F S Rosen; R W Carrell; P J Lachmann; R A Harrison
Journal:  Biochem J       Date:  1988-07-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.